XOLACTA Trademark

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; drug delivery systems in the nature of exosomes for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; exosome-based drug delivery systems for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; exosomes for medical purposes for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; exosomes for therapeutic purposes for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; biological preparations comprising exosomes for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; synthetic peptides for the treatment of internal diseases and wounds for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; exosomes loaded with synthetic peptides for the treatment of internal diseases and wounds caused by cardiovascular, neurological, and inflammatory diseases and disorders, cancer, radiation sickness, and radiotherapy